Screener

Eligibility screening

BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

Sponsored by Bristol-Myers SquibbStudy detailsClinicalTrials.gov

11 US sites in CA, IA, NJ, NY +3

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.